This company listing is no longer active
Chinook Therapeutics Management
Management criteria checks 2/4
Chinook Therapeutics' CEO is Eric Dobmeier, appointed in Apr 2019, he has a tenure of 4.33 years. His total yearly compensation is $4.84M , comprised of 12.4% salary and 87.6% bonuses, including company stock and options. He directly owns 0.42% of the company’s shares, worth €11.11M. The average tenure of the management team and the board of directors is 2.2 years and 3.5 years respectively.
Key information
Eric Dobmeier
Chief executive officer
US$4.8m
Total compensation
| CEO salary percentage | 12.4% |
| CEO tenure | 4.3yrs |
| CEO ownership | 0.4% |
| Management average tenure | 2.2yrs |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -US$246m |
| Mar 31 2023 | n/a | n/a | -US$216m |
| Dec 31 2022 | US$5m | US$601k | -US$188m |
| Sep 30 2022 | n/a | n/a | -US$118m |
| Jun 30 2022 | n/a | n/a | -US$92m |
| Mar 31 2022 | n/a | n/a | -US$97m |
| Dec 31 2021 | US$4m | US$547k | -US$103m |
| Sep 30 2021 | n/a | n/a | -US$160m |
| Jun 30 2021 | n/a | n/a | -US$149m |
| Mar 31 2021 | n/a | n/a | -US$114m |
| Dec 31 2020 | US$6m | US$438k | -US$82m |
Compensation vs Market: Eric's total compensation ($USD4.84M) is above average for companies of similar size in the German market ($USD2.55M).
Compensation vs Earnings: Eric's compensation has increased whilst the company is unprofitable.
CEO
Eric Dobmeier (54 yo)
4.3yrs
Tenure
US$4,841,699
Compensation
Mr. Eric L. Dobmeier, J.D., has been an Independent Director at Structure Therapeutics Inc. since December 2022. He is the President, Chief Executive Officer and Director of Chinook Therapeutics, Inc. sinc...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.3yrs | US$4.84m | 0.42% € 11.1m | |
| Chief Operating Officer | 2.2yrs | US$2.02m | 0.21% € 5.6m | |
| Chief Scientific Officer | 2.2yrs | US$2.23m | 0.027% € 706.8k | |
| Chief Financial Officer | 2.8yrs | no data | 0.054% € 1.4m | |
| Senior Vice President of Finance & Accounting | less than a year | no data | no data | |
| Senior Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Senior VP & General Counsel | no data | no data | no data | |
| Senior Vice President of Human Resources | no data | no data | no data | |
| Executive Officer | 3.3yrs | US$2.41m | 0.011% € 291.2k | |
| Senior Vice President of CMC & Technical Operations | 2.3yrs | no data | no data | |
| Senior Vice President of Product Development & Strategy | 1.6yrs | no data | no data | |
| Chief Commercial Officer | less than a year | no data | no data |
2.2yrs
Average Tenure
49yo
Average Age
Experienced Management: 290A's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.3yrs | US$4.84m | 0.42% € 11.1m | |
| Independent Director | 2.8yrs | US$233.60k | 0.0046% € 121.9k | |
| Independent Director | 4.1yrs | US$227.60k | 0.0046% € 121.9k | |
| Independent Director | 13.2yrs | US$233.10k | 0.033% € 872.4k | |
| Independent Director | 1.4yrs | US$451.98k | 0.0018% € 47.2k | |
| Independent Lead Director | 4.7yrs | US$244.60k | 0.62% € 16.5m | |
| Independent Director | less than a year | no data | 0% € 0 | |
| Independent Director | 2.8yrs | US$217.60k | 0.019% € 490.7k |
3.5yrs
Average Tenure
54.5yo
Average Age
Experienced Board: 290A's board of directors are considered experienced (3.5 years average tenure).